Literature DB >> 22580800

Acute stroke treatment using the Penumbra endovascular mechanical thrombolysis device: a single-centre experience.

R Gandini1, E Pampana, C Del Giudice, F Massari, S Spano, E P Assako Ondo, E Salvatori, F Sallustio, G Koch, P Stanzione, G Simonetti.   

Abstract

PURPOSE: Ischaemic stroke due to occlusion of large cerebral vessels has a poor prognosis. The clinical outcome is related to efficacy and timing of recanalisation of the occluded arteries. We report our experience with a thrombus aspiration device (Penumbra), and focus on pre- and postprocedural management.
MATERIALS AND METHODS: We retrospectively reviewed 18 consecutive patients with acute ischaemic stroke due to the occlusion of large cerebral vessels who were treated with mechanical thrombolysis at our centre between September 2009 and July 2010. Preprocedural symptoms were quantified using the National Institutes of Health Stroke Scale (NIHSS). Mechanical thrombolysis was performed with the Penumbra system. Intravenous thrombolysis was done only if <3 h had elapsed since symptom onset. Associated vessel stenoses were treated with stenting. All patients underwent neurological examination and postprocedural magnetic resonance angiography (MRA) at 3 and 6 months.
RESULTS: Mechanical thrombolysis using the Penumbra system was performed in all cases. A total of 83% of treated vessels had a value of 2/3 according to the Thrombolysis in Cerebral Infarction (TICI) scale. In seven patients (39%) intravenous thrombolysis was unsuccessful, and salvage mechanical thrombolysis followed. Three patients died after the procedure (16.7%). Five patients (27.8%) required a stenting procedure. All patients reported a significant improvement in symptoms (mean baseline NIHSS 19.6±5.6; mean postprocedural NIHSS, 7.8±5.5 p<0.0001)
CONCLUSIONS: Our preliminary experience with the Penumbra mechanical thrombolysis system confirms previously reported results showing the efficacy and safety of the device in treating acute stroke caused by the occlusion of large intracranial vessels.

Entities:  

Mesh:

Year:  2012        PMID: 22580800     DOI: 10.1007/s11547-012-0819-5

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  20 in total

1.  C-reactive protein and outcome after ischemic stroke.

Authors:  K W Muir; C J Weir; W Alwan; I B Squire; K R Lees
Journal:  Stroke       Date:  1999-05       Impact factor: 7.914

2.  Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I.

Authors:  W S Smith
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

3.  Reliability and validity of estimating the NIH stroke scale score from medical records.

Authors:  S E Kasner; J A Chalela; J M Luciano; B L Cucchiara; E C Raps; M L McGarvey; M B Conroy; A R Localio
Journal:  Stroke       Date:  1999-08       Impact factor: 7.914

Review 4.  C-reactive protein and venous thromboembolism: causal or casual association?

Authors:  Giuseppe Lippi; Emmanuel J Favaloro; Martina Montagnana; Massimo Franchini
Journal:  Clin Chem Lab Med       Date:  2010-08-13       Impact factor: 3.694

5.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Stroke       Date:  2007-04-12       Impact factor: 7.914

6.  Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.

Authors:  Peter U Heuschmann; Klaus Berger; Bjoern Misselwitz; Peter Hermanek; Carsten Leffmann; Michael Adelmann; Hans-Joachim Buecker-Nott; Joachim Rother; Bernhard Neundoerfer; Peter L Kolominsky-Rabas
Journal:  Stroke       Date:  2003-03-27       Impact factor: 7.914

7.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

8.  Penumbra Stroke System as an "add-on" for the treatment of large vessel occlusive disease following thrombolysis: first results.

Authors:  Tobias Struffert; Martin Köhrmann; Tobias Engelhorn; Tim Nowe; Gregor Richter; Peter D Schellinger; Stefan Schwab; Arnd Doerfler
Journal:  Eur Radiol       Date:  2009-04-07       Impact factor: 5.315

9.  Quantitative assessment of core/penumbra mismatch in acute stroke: CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged.

Authors:  Pamela W Schaefer; Elizabeth R Barak; Shahmir Kamalian; Leila Rezai Gharai; Lee Schwamm; Ramon Gilberto Gonzalez; Michael H Lev
Journal:  Stroke       Date:  2008-08-21       Impact factor: 7.914

10.  Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.

Authors:  Andrei V Alexandrov; Carlos A Molina; James C Grotta; Zsolt Garami; Shiela R Ford; Jose Alvarez-Sabin; Joan Montaner; Maher Saqqur; Andrew M Demchuk; Lemuel A Moyé; Michael D Hill; Anne W Wojner
Journal:  N Engl J Med       Date:  2004-11-18       Impact factor: 91.245

View more
  1 in total

Review 1.  What is meant by "TICI"?

Authors:  J E Fugate; A M Klunder; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2013-04-11       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.